PURPOSE: End-of-life sedation, though increasingly prevalent and widespread internationally, remains one of the most highly debated medical practices in the context of palliative medicine. This qualitative study aims to elicit and record the perspectives of leading international palliative care experts on current debates. METHODS: Twenty-one professionals from diverse backgrounds, sharing field-specific knowledge/expertise defined by significant scholarly contribution on end-of-life sedation, were recruited. Open-ended, semi-structured interviews, following a topic-oriented structure reflecting on current debates, were conducted. Results were analysed using thematic content analysis. RESULTS: Three main aspects of sedation were identified and discussed as potentially problematic: (a) continuous deep sedation as an extreme facet of end-of-life sedation, (b) psycho-existential suffering as an ambivalent indication for sedation and (c) withdrawal or withholding of artificial nutrition and hydration as potentially life-shortening. On these grounds, concerns were reported over end-of-life sedation being morally equivalent to euthanasia. Considerable emphasis was placed on intentions as the distinguishing factor between end-of-life acts, and protective safeguards were introduced to distance sedation from euthanasia. CONCLUSIONS: This study shows that, despite the safeguards introduced, certain aspects of sedation, including the intentions associated with the practice, are still under question, parallels being drawn between end-of-life sedation and euthanasia. This reaffirms the existence of a grey area surrounding the two practices, already evidenced in countries where euthanasia is legalized. More clarity over the issues that generate this grey area, with their causes being uncovered and eliminated, is imperative to resolve current debates and effectively inform research, policy and practice of end-of-life sedation.
PURPOSE: End-of-life sedation, though increasingly prevalent and widespread internationally, remains one of the most highly debated medical practices in the context of palliative medicine. This qualitative study aims to elicit and record the perspectives of leading international palliative care experts on current debates. METHODS: Twenty-one professionals from diverse backgrounds, sharing field-specific knowledge/expertise defined by significant scholarly contribution on end-of-life sedation, were recruited. Open-ended, semi-structured interviews, following a topic-oriented structure reflecting on current debates, were conducted. Results were analysed using thematic content analysis. RESULTS: Three main aspects of sedation were identified and discussed as potentially problematic: (a) continuous deep sedation as an extreme facet of end-of-life sedation, (b) psycho-existential suffering as an ambivalent indication for sedation and (c) withdrawal or withholding of artificial nutrition and hydration as potentially life-shortening. On these grounds, concerns were reported over end-of-life sedation being morally equivalent to euthanasia. Considerable emphasis was placed on intentions as the distinguishing factor between end-of-life acts, and protective safeguards were introduced to distance sedation from euthanasia. CONCLUSIONS: This study shows that, despite the safeguards introduced, certain aspects of sedation, including the intentions associated with the practice, are still under question, parallels being drawn between end-of-life sedation and euthanasia. This reaffirms the existence of a grey area surrounding the two practices, already evidenced in countries where euthanasia is legalized. More clarity over the issues that generate this grey area, with their causes being uncovered and eliminated, is imperative to resolve current debates and effectively inform research, policy and practice of end-of-life sedation.
Authors: Lauris C Kaldjian; Barry J Wu; James N Kirkpatrick; Asha Thomas-Geevarghese; Mary Vaughan-Sarrazin Journal: Am J Hosp Palliat Care Date: 2004 Sep-Oct Impact factor: 2.500
Authors: J A C Rietjens; H M Buiting; H R W Pasman; P J van der Maas; J J M van Delden; A van der Heide Journal: Palliat Med Date: 2009-03-20 Impact factor: 4.762
Authors: H M Buiting; A van der Heide; B D Onwuteaka-Philipsen; M L Rurup; J A C Rietjens; G Borsboom; P J van der Maas; J J M van Delden Journal: J Med Ethics Date: 2010-01 Impact factor: 2.903
Authors: Livia Anquinet; Judith A C Rietjens; Lieve Van den Block; Nathalie Bossuyt; Luc Deliens Journal: Eur J Gen Pract Date: 2010-12-21 Impact factor: 1.904
Authors: Vincent Gamblin; Vincent Berry; Emmanuelle Tresch-Bruneel; Michel Reich; Arlette Da Silva; Stéphanie Villet; Nicolas Penel; Chloé Prod'Homme Journal: BMC Palliat Care Date: 2020-06-19 Impact factor: 3.234
Authors: Patrick Hoek; Ilse Grandjean; Constans A H H V M Verhagen; Marlies L E A Jansen-Landheer; Henk J Schers; Cilia Galesloot; Kris C P Vissers; Yvonne Engels; Jeroen G J Hasselaar Journal: PLoS One Date: 2015-08-24 Impact factor: 3.240